PubMed COVID-19 Clinical Care

[This corrects the article DOI: 10.1371/journal.pone.0284248.].

The currently available coronavirus disease 2019 (COVID-19) vaccines in South Korea include mRNA (Moderna^(®) and Pfizer^(®)) and adenoviral vector (AstraZeneca^(®) and Janssen^(®)) vaccines. Dermatologic side effects of COVID-19 vaccines range from

CONCLUSIONS: Our results agree with most of the literature data that anxiety, depression, and stress are associated with gender (female), age (18-44 vs. over 55), and having cared for patients with COVID-19.

Background and objective Characterizing the epidemiological features of coronavirus disease 2019 (COVID-19) is highly important for developing and implementing effective control measures against it. However, there is scarce data about the presenting

This report presents an atypical case of neuroretinitis in a post-transplant patient. A man in his 40s presented to a provincial ophthalmology service with unilateral left visual loss. He was immunosuppressed following orthotopic liver

When the COVID-19 pandemic first emerged in early 2020, healthcare and bureaucratic systems worldwide were caught off guard and largely unprepared to deal with the scale and severity of the outbreak. In Italy, this led to a severe underreporting of

Current clinical guidelines support the concomitant administration of seasonal influenza vaccines and COVID-19 mRNA vaccine boosters. Whether dual vaccination may impact vaccine immunogenicity due to an interference between influenza or SARS-CoV-2

CONCLUSION: A two-months intermission of performing elective cataract surgery does not cause an increase in complications. In contrast, we observe a reduction of postoperative complications. This implicates that refraining from cataract surgery for

Most Australian adults now have hybrid immunity to the SARS-CoV-2 virus, referring to a combination of protection from previous vaccine doses and past infection. Protection from both vaccination and past infection wanes over time. Booster doses are

SARS-CoV-2 constantly circulates and evolves worldwide, generating many variants and posing a menace to global health. It is urgently needed to discover effective medicines to treat the disease caused by SARS-CoV-2 and its variants. An established